Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles
Soufyane Hba, Suzan Ghaddar, Hicham Wahnou, Aline Pinon, Riad El Kebbaj, Christelle Pouget, Vincent Sol, Bertrand Liagre, Mounia Oudghiri, Youness Limami, Montse Mitjans Arnal · 2023
Read Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles by Soufyane Hba, Suzan Ghaddar, Hicham Wahnou, Aline Pinon, Riad El Kebbaj, Christelle Pouget, Vincent Sol, Bertrand Liagre, Mounia Oudghiri, Youness Limami, Montse Mitjans Arnal (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10748144.txt.
Description
Soufyane Hba and co-authors review chalcones, a family of plant compounds, as candidate drugs for colon cancer, in work published in 2023. Colon cancer is a major global health burden and needs new treatment approaches. Chalcones can interfere with several signalling pathways that drive the cancer's growth and spread.
The review covers how natural chalcones and their derivatives act on cancer cells. It stresses that most evidence is still pre-clinical, so safety and efficacy in patients remain unproven. Open problems include how to order treatments, how resistance arises, and how chalcones pair with other therapies. Loading chalcones into nanoparticles may deliver them to tumours more effectively. The authors map both the promise and the work still needed before clinical use.
Catalog record
| CREATOR | Soufyane Hba, Suzan Ghaddar, Hicham Wahnou, Aline Pinon, Riad El Kebbaj, Christelle Pouget, Vincent Sol, Bertrand Liagre, Mounia Oudghiri, Youness Limami, Montse Mitjans Arnal |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |